Qualigen Therapeutics Inc. buy melinda
Start price
24.03.17
/
50%
€4,059.0
Target price
30.03.17
€7,892.5
Performance (%)
-11.11%
End price
30.03.17
€3,608.0
Summary
This prediction ended on 30.03.17 with a price of €3,608.0. The prediction for Qualigen Therapeutics Inc. disappointed with a performance of -11.11%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Qualigen Therapeutics Inc. | -17.822% | -17.822% | -80.742% | -99.051% |
iShares Core DAX® | 0.238% | -2.265% | 13.679% | 14.917% |
iShares Nasdaq 100 | -0.304% | 5.808% | 34.538% | 52.796% |
iShares Nikkei 225® | 2.271% | 1.577% | 9.436% | 5.432% |
iShares S&P 500 | -0.296% | 4.447% | 28.577% | 47.257% |
According to melinda what are the pros and cons of Qualigen Therapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Ritter Pharmaceuticals Inc diskutieren
Gesundheit | Biotechnologie | Vereinigte Staaten
A +
(Vom Mitglied beendet)
Stopped prediction by melinda for Qualigen Therapeutics Inc.
Qualigen Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.72
22.11.22
22.11.22
-
22.11.23
22.11.23
-66.14%
23.11.23
23.11.23
Could be worthwhile Investment >10% per year
Qualigen Therapeutics Inc.
Start price
Target price
Perf. (%)
€631.40
26.02.18
26.02.18
€1,127.5
27.08.18
27.08.18
-31.07%
27.08.18
27.08.18
Could be worthwhile Investment >10% per year
Qualigen Therapeutics Inc.
Start price
Target price
Perf. (%)
€3,057.6
03.04.17
03.04.17
€6,765.0
03.10.17
03.10.17
-73.08%
03.10.17
03.10.17
Could be worthwhile Investment >10% per year